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ABSTRACT
Coronavirus disease 2019 (COVID-19) is a communicable disease caused with newly discovered severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2). The virus that causes COVID-19 is mainly transmitted through droplets generated when an infected person coughs, sneezes, or exhales. 
These droplets are too heavy to suspend in the air and quickly fall on floors or surfaces. Persons can be infected by touching contaminated surface 
and then to touching their eyes, nose, or mouth. This disease since December 2019 when first was identified spread globally, resulting in the on-going 
2019–20 coronavirus pandemic. As of May 8, 2020, more than 3,916,338 cases have been reported across 185 countries and territories, resulting in 
more than 270,711 deaths. More than 1,343,054 people have recovered. The purpose of this review article was to study preventive and measurable 
actions implemented by the respective countries nationwide to prevent COVID-19’s severity, spread, and mortality. The most affected nations were 
the USA, Spain, Italy, the UK, France, and Germany, and less affected India, whereas countries like New Zealand were not much affected. To this date, 
India was able to control spread of COVID-19 due to early measurable preventive control on this disease. The study including recovered rate of disease, 
growth rate of disease, and mortality rate was carried out for these countries. The study proved that measurable actions such as lockdown imposing 
and social distance maintenance were effective to prevent spread of COVID-19 and would be effective, as currently, there is no vaccine or specific 
antiviral treatment for this.
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INTRODUCTION
Origin and spread
Coronavirus disease 2019 (COVID-19) is an infectious disease cause by 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The 
disease was first recognized in December 2019 in Wuhan, the capital of 
China’s Hubei region, and has since spread globally, resulting in the on-
going 2019–20 coronavirus pandemic [1]. A molecular dating estimate 
based on the SARS-CoV-2 genomic sequences indicates an origin in 
November. This raises questions about the link between this COVID-19 
epidemic and wildlife.
The virus is primarily spread between people throughout close contact, 
often through small droplets produced by coughing, sneezing, or 
talking. The droplets usually drop to the ground or onto surfaces rather 
than remaining in the air over long distances. People may also become 
infected by touching a contaminated surface and then touching their 
face. In experimental settings, the virus may survive on surfaces for 
up to 72 h. It is most infectious during the first 3 days after the onset 
of symptoms, although spread may be possible before symptoms 
appear and in later stages of the disease. Most people infected with 
the COVID-19 virus will experience mild-to-moderate respiratory 
illness and get well without requiring special treatment. Older people 
and those with underlying medical problems such as cardiovascular 
disease, diabetes, chronic respiratory disease, and cancer are more 
likely to develop serious illness [2].
Common symptoms
The COVID-19 virus affects different people in different ways. 
COVID-19 is a respiratory disease and most infected people will 
develop mild-to-moderate symptoms and recover without requiring 
special treatment. People who have fundamental medical conditions 




•	 Tiredness and fatigue
•	 Dry cough
•	 Loss of smell
Other symptoms include
•	 Shortness of breath
•	 Aches and pains
•	 Sore throat
•	 And very few people will report diarrhea, nausea, or a runny nose.
While the majority of cases result in mild symptom, some progress to viral 
pneumonia, multiorgan failure, or cytokine storm [3]. More concerning 
symptoms include difficulty breathing, persistent chest pain, confusion, 
difficulty waking, and bluish skin [4]. The time from contact to onset of 
symptoms is typically around 5 days but may range from 2 to 14 days [5].
Diagnosis
The standard method of diagnosis is by real-time reverse transcription 
polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab. 
Chest CT imaging might also be helpful for diagnosis in individuals 
where there is a high suspicion of infection based on symptoms and 
risk factors; however, guidelines do not recommend using it for routine 
screening [6].
Recommended measures to prevent infection include [7,8]
•	 Frequent handwashing with soap and water, or clean them with 
alcohol-based hand rub.
•	 Maintaining physical distance from others (especially from those by 
means of symptoms),
•	 Cover your lips and nose when coughing or sneezing, and keeping 
unwashed hands away from the face.
•	 Stay home if you feel unwell.
Review Article
Innovare Journal of Medical Science, Vol 8, Issue 4, 2020, 1-6
 Dyade et al. 
2
•	 Refrain from smoking and other activities so as to weaken the lungs.
•	 Practice physical distancing by avoiding needless travel and staying 
away from large groups of people.
In addition, the use of a face covering is recommended for those who 
suspect they have the virus and their caregivers. Recommendations 
for face covering use by the general public vary, with some authorities 
recommending against their use, some recommending their use, and 
others requiring their use. At present, there is not sufficient evidence 
for or against the use of masks (medical or other) in healthy individuals 
in the wider community.
Risk factors
Without taking proper prevention measures, peoples are also at high 
risk if
•	 Live with someone who has contracted the virus
•	 Are providing home care for a big shot who has contracted the virus
•	 Have an intimate partner who has thin the virus
Older people and people with certain health conditions have a higher 
risk for severe complications if they contract the virus. These health 
conditions include:
•	 Lung conditions, such as COPD and asthma
•	 Certain heart conditions
•	 Resistant system conditions, such as HIV
•	 Cancer that requires treatment
•	 Severe obesity
•	 Other health conditions, if not well-controlled, such as diabetes, 
kidney disease, or liver disease
• Pregnant women have a higher risk of complications from other viral 
infections, but it’s not yet known if this is the case for COVID-19.
Virology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a 
novel severe acute respiratory syndrome coronavirus, primary isolated 
from three people with pneumonia connected to the clustery of acute 
respiratory illness cases in Wuhan [9]. All kinds of the novel SARS-
CoV-2 virus occur in related coronaviruses in nature [10]. Outside the 
person body, the virus is killed by household soap, which bursts its 
protective bubble [6].
Genomic data
The SARS-CoV-2 (Fig. 1) genome was rapidly sequenced by Chinese 
researchers. It is an RNA molecule of about 30,000 bases containing 15 
genes, including the S gene which codes for a protein located on the 
surface of the viral envelop [11].
SARS-CoV-2 is closely related to the original SARS-Co [12]. It is thought 
to have a zoonotic origin. Genetic analysis has revealed the coronavirus 
hereditarily clusters with the genus Betacoronavirus, in subgenus 
Sarbecovirus (lineage B) jointly with two bat-derived strains. It is 96% 
identical at the whole genome height to other bat coronavirus sample 
(BatCov RaTG13) [13]. In February 2020, Chinese researchers establish 
that there is only one amino acid difference in the binding domain of 
the S protein between the coronaviruses from pangolins and those 
from humans; though, whole-genome comparison to date establish 
that at most 92% of genetic material was shared between pangolin 
coronavirus and SARS-CoV-2, which is insufficient to show pangolins to 
be the intermediate host [14].
Current treatment and therapies [15]
Examples of therapies used for these illnesses include
•	 As mechanical ventilation
•	 Steroids to reduce lung antiviral or retroviral medications
•	 Breathing support, such swelling
•	 Blood plasma transfusions.
At present, there is no vaccine or specific antiviral treatment for 
COVID-19. Management involves the treatment of symptoms, supportive 
care, isolation, and new measures. The World Health Organization 
(WHO) declared the 2019–20 coronavirus outbreak a Public Health 
Emergency of International Concern (PHEIC) on January 30, 2020, and 
a pandemic on March 11, 2020. Local transmission of the disease has 
occurred in mainly countries across all six WHO regions.
Recent update on development of vaccine [16]
•	 The US-based Pharma giant Pfizer has already injected the first 
experimental vaccine on patients. Remdesivir has been showing 
“very promising” results as antiviral drug in a crucial study in the US.
•	 Israel government’s Institute for Biological Research (IIBR) has 
developed an antibody to the novel coronavirus and is going to patent 
and mass produce the potential treatment.
•	 In China, the US-based Inovio Pharmaceuticals has attempted DNA-
based vaccine. Chinese vaccines are under fast development and 
now undergoing Phase 1 and Phase 2 human trials includes CanSino 
Biological Inc.-Beijing Institute of Biotechnology, Wuhan Institute 
of Biological Products-Sinopharm, Beijing Institute of Biological 
Products with Sinopharm, and an independent SARS platform-based 
inactivated vaccine from Sinovac.
•	 Serum biological Institute, Pune, Maharashtra (India), collaboration 
with Oxford team has started human trials of a vaccine produced.
Global strategy to respond to COVID-19 [17]
The overarching goal is for all countries to manage the pandemic by 
slowing down the transmission and reducing mortality associated with 
COVID-19. The global strategic objectives are as follows:
•	 Mobilize all sectors and communities to make sure that every division 
of government and society takes ownership of and participate in the 
response and in preventing cases through hand hygiene, respiratory 
etiquette, and individual level physical distancing.
•	 Control sporadic cases and clusters and prevent community 
broadcast by fast finding and isolating all cases, providing them with 
suitable care, and tracing, quarantining, and supporting all contacts.
•	 Suppress neighborhood transmission through context-appropriate 
infection prevention and control measures, population level physical 
distancing measures, and appropriate and proportionate limits on 
non-essential domestic and global travel.
•	 Reduce mortality by providing suitable clinical care for those 
pretentious by COVID19, ensuring the continuity of essential health 
and social services, and protecting frontline workers and vulnerable 
populations.
•	 Develop safe and effectual vaccines and therapeutics that can be 
deliver at scale and that are accessible based on need.
Country wise data reviewed up to May 7, 2020 [15,17-19]
Country wise data related to first case of disease, first death reported, 
measurable preventive actions, and present situation of the disease 
spread was reviewed
USA [18,19]
The first U.S. case of COVID-19 was reported on January 20, 2020, in a 
man who had returned from Wuhan, China to Washington on January 
15, 2020. The first report of the U.S. death came on February 29, 2020. 
Earlier the first known U.S. death from COVID-19 occurred on February 
6, 2020, in Santa Clara colony, California, but it was reported in late 
April. On January 31, 2020, the USA administration through the U.S. 
Department of Health and Human Services declared a public health 
emergency and imposed mandatory 14 days quarantine for any U.S. 
citizens who have visited Hubei Province in China within preceding 2 
weeks. It also began denying entry of non-US. The total cases and total 
death are graphically represented in Fig. 2.
Spain [18,20]
The COVID-19 pandemic was confirmed to have increase to Spain on 
January 31, 2020, when a German tourist tested positive for SARS-
CoV-2 in La Gomers, Canary Islands. On February 13, 2020, the first 
death in Spain was recorded involving a 69-year-old man who had been 
in Nepal. He died in Valencia and was diagnosed postmortem. By March 
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13, 2020, cases had been confirmed in all 50 provinces of the country. 
A state of alarm and nationwide lockdown was imposed on March 14, 
2020. On March 29, it was announced that all non-essential workers 
were to stay home for the next 14 days. The total cases and total death 
are graphically represented in Fig. 3.
Italy [18,21]
COVID-19 was first confirmed to have spread to Italy on January 31, 
2020, when two Chinese tourists in Rome tested positive for the virus. 
First death was confirmed on February 22, 2020. On January 31, the 
govt. suspended all flights to and from China and declared a state of 
emergency. On March 9, 2020, govt. ordered quarantine to all Italy. On 
March 21, Italian govt. closed all non-essential business and industries 
and restricted movement of people. The total cases and total death are 
graphically represented in Fig. 4.
United Kingdom UK [18,22]
COVID-19 spread to the UK in late January 2020. On January 31, 2020, 
two cases were confirmed in the UK. On March 5, 2020, the first death 
reported in the UK. On March 20, 2020, all schools, restaurants, pubs, 
clubs, and indoor leisure facilities were ordered to shut. On March 23, 
the govt. imposed a lockdown on the whole population banning all 
non-essential travel and contact with people outside one’s home, and 
shutting almost all business, venues, facilities, and places of worship.
The total cases and total death are graphically represented in Fig. 5.
France [18,23]
COVID-19 pandemic reached France on January 24, 2020, when the first 
COVID-19 case in Europe and France was confirmed in Bordeaux. The 
first five confirmed cases be all individuals who had recently arrived or 
returned from China. A Chinese traveler who was admitted to hospital Fig. 1: The diagram of Coronavirus
Fig. 2: (a) Total cases of COVID-19 infected and (b) death in the USA per week from February 5, 2020
a b
Fig. 3: (a) Total cases of COVID-19 infected and (b) death in Spain per week from February 5, 2020
a b
Fig. 4: (a) Total cases of COVID-19 infected and (b) death in Italy per week from February 5, 2020
a b
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in Paris on January 28, 2020, then died on February 14 making it 
the first COVID-19 death in France. On March 12, the govt. in France 
announced on public television that all schools and all universities 
would close from Monday March 16, 2020, until further notice. On 
March 16, 2020, govt. announced mandatory home confinement for 15 
days starting on March 17. This was extended twice until May 11, 2020. 
The total cases and total death are graphically represented in Fig. 6.
Germany [18,24]
The on-going COVID-19 pandemic spread to Germany on January 
27, 2020, when the first case was confirmed and contained near 
Munich, Bavaria. On February 25 and 26, multiple cases connected 
to the Italian outbreak be detected in Baden. The first death was 
reported on March 9, 2020. German disease and epidemic control are 
advised by the Robert Koch Institute (RKI) according to a national 
pandemic plan. Since March 13, the pandemic has been managed in 
the protection stage as per the RKI plan, with German states mandate 
school and kindergarten closures, postponing academic semesters, 
and prohibiting visits to nursing homes to protect the elderly. Two 
days later, borders to five neighboring countries were closed. By March 
22, all regional governments had announced curfews or restrictions 
in public spaces. The total cases and total death are graphically 
represented in Fig. 7.
India [18,25]
On January 30, 2020, India reported its first case of COVID-19 in Kerala, 
which rose to three cases by February 3, 2020; all were students who 
had returned from Wuhan, China. No significant rise in cases was seen 
in the rest of February 2020. On March 4, 2020, 22 new cases came 
to light, including those of an Italian tourist group with 14 infected 
members. On March 12, 2020, a 76-year-old man who had returned 
from Saudi Arabia became the first victim of the virus in the country.
On March 22, 2020, India observed a 14 h voluntary public curfew at the 
instance of the govt. The government followed it up with lockdowns in 
75 districts where COVID cases had occurred as well as all major cities. 
Further, on March 24, 2020, the govt. ordered a nationwide lockdown for 
21 days, affecting the entire 1.3 billion population of India. On April 14, 
2020, the govt. extended the on-going nationwide lockdown till May 3, 
2020. The total cases and total death are graphically represented in Fig. 8.
New Zealand [18,26]
New Zealand confirmed its first case on February 28, 2020, a New 
Zealand citizen in her 60s who had recently visited Iran, returning 
through Bali, Indonesia, and arriving in New Zealand on February 26, 
2020, at Auckland. She had two tests for COVID-19 that was negative, 
but a third test using a more specific sample was positive. She was 
Fig. 5:  (a) Total cases of COVID-19 infected and (b) death in the UK per week from February 5, 2020
a b
Fig. 6: (a) Total cases of COVID-19 infected and (b) death in France per week from February 5, 2020
ba
Fig. 7: (a) Total cases of COVID-19 infected and (b) death in Germany per week from February 5, 2020
a b
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admitted to Auckland city. The first case of the pandemic of COVID-19 
in New Zealand was reported on February 28, 2020. On February 3, the 
New Zealand Government announce that foreign travelers who left from 
China would be denied entry to New Zealand, with only New Zealand 
citizens and permanent residents and their family being allowed to 
enter. On March 21, the govt. announced the foreword of a countrywide 
alert level system, similar to the existing fire warning systems. There 
are four levels, with 1 being the least risk of infection and 4 the highest. 
At the time of the announcement, New Zealand was at level 2. Each level 
brings added restrictions on activities or movements. Each region can 
have an individual alert level based on the severity of their infections, 
and these levels can be changed at any time. The total cases and total 
death are graphically represented in Fig. 9.
RESULTS AND CONCLUSION
In many countries, COVID-19 was first detected in January. In March and 
April, total cases were increased though stringent remedy implemented 
by all these countries to prevent and spread of pandemic disease. Data 
of April 21–May 6 period show decrease in death rate as compare to 
data of April 6–April 21 period show expected results due to preventive 
action by countries globally. Recovery data of each country were shown 
gradual increase in recovery rate to May 6. Table 1 shows updated data 
on May 7, 2020.
Table 1: 8 Country wise COVID-19 data [18,19-26]
Country name USA Spain Italy UK France Germany India New Zealand
Data
Total cases reported 1,263,092 253,682 214,457 201,101 174,191 168,162 52,987 1483
Total recovered 217,250 163,919 96,276 NA 55,027 141,700 16,776 1347
% of (May 6, April 21, 




















Total mortality 74799 25851 29684 30076 25809 7275 1787 21
% of death in (May 6, 

























NA: Data not available
It is concluded that measurable prevention took by these nations were 
appreciably increased the recovery rate and decreased daily outcome 
total cases of COVID-19. At present, social distance maintaining and self-
quarantine are worthy remedy to avoid and keep away from COVID-19.
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